← Leaderboards
Claudene George
Albert Einstein College Of Medicine
$772,454
Attributed
$772,454
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $160K · FY2020–24$200K$150K$100K$50K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$772,454 · 1
By mechanism
K23$772,454 · 1
Top collaborators
No co-investigators on record.
Most similar at Albert Einstein College Of Medicine
Same institution · by research overlap
- Joe Verghese$39,214,466
- Roee Holtzer$11,798,037
- Pavagada S Mathuranath$2,489,042
- Matthew K Abramowitz$4,556,144
- Anjali Sharma$19,812,193
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposCoupledBrainAngiotensin-Converting Enzyme InhibitorsConsumptionAttentionAcetylcholineAffectBiologicalBiometryAngiotensin IiAgingBlood PressureBlood VesselsCohortCareerCareer DevelopmentAwardCerebrovascular CirculationClinically RelevantClinical MarkersCognitionCognitiveCytokine
Grant awards (5)
Utility of Centrally Acting Angiotensin Converting Enzyme Inhibitors to slow the progression of Dementia$150,886
K23 · FY2024 · AG · contact PI
Utility of Centrally Acting Angiotensin Converting Enzyme Inhibitors to slow the progression of Dementia$150,763
K23 · FY2023 · AG · contact PI
Utility of Centrally Acting Angiotensin Converting Enzyme Inhibitors to slow the progression of Dementia$154,812
K23 · FY2022 · AG · contact PI
Utility of Centrally Acting Angiotensin Converting Enzyme Inhibitors to slow the progression of Dementia$159,960
K23 · FY2021 · AG · contact PI
Utility of Centrally Acting Angiotensin Converting Enzyme Inhibitors to slow the progression of Dementia$156,033
K23 · FY2020 · AG · contact PI